Paroxetine Tablet, Film Coated
Product Images NDC 0378-7002

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 0378-7002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure of paroxetine hydrochloride hemihydrate, showing the molecular arrangement of the active ingredient with labeled chemical bonds and atoms including fluorine (F), hydrochloride (HCl), and water of hydration (1/2 H2O).*

FDA Label Image

Image 02

Paroxetine 10 mg film-coated oral tablets label from Mylan Pharmaceuticals Inc. The label states the active ingredient as paroxetine hydrochloride USP (hemihydrate) equivalent to 10 mg paroxetine per tablet, with a package count of 30 tablets. Instructions for dispensing, storage, and warnings about child-resistant containers are included, along with the Mylan logo and contact information.*

FDA Label Image

Image 03

Paroxetine 20 mg film-coated tablets label from Mylan Pharmaceuticals Inc., containing 30 tablets. The label states the active ingredient as paroxetine hydrochloride hemihydrate equivalent to 20 mg paroxetine per tablet. It includes dosing information, pharmacist dispensing instructions, storage conditions, and child-resistant packaging warnings. The label shows the NDC 0378-7002-93 and Mylan logos.*

FDA Label Image

Image 04

Paroxetine 30 mg film-coated tablets, USP, by Mylan Pharmaceuticals Inc. The label includes the NDC 0378-7003-93 and indicates a package of 30 tablets for oral use. It features dispensing instructions for pharmacists and storage guidance, with the medication made in Australia.*

FDA Label Image

Image 05

Label for Paroxetine 40 mg film-coated oral tablets by Mylan Pharmaceuticals Inc. The label includes the NDC 0378-7004-93 and specifies that the package contains 30 tablets. It features pharmacist dispensing instructions, storage conditions (20° to 25°C), and safety warnings about keeping medication out of reach of children and using child-resistant containers. The product is made in Australia.*

FDA Label Image

Image 06

A scatter plot graph showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs including Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Image 07

A forest plot chart showing the pharmacokinetic interactions of paroxetine with various drugs including cimetidine, phenobarbital, phenytoin, digoxin, and diazepam. The chart displays fold changes and 90% confidence intervals for Cmax and AUC values relative to reference, illustrating the impact on drug concentration and exposure.*

FDA Label Image

Image 08

A forest plot chart showing pharmacokinetic fold changes and 90% confidence intervals of paroxetine in populations with varying renal and hepatic impairment, different ages over 65 years at multiple doses, and gender (males). The x-axis represents change relative to reference, ranging from 0.5 to 50. Variables shown include Cmax, Cmin, and AUC parameters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.